Bettina Hederer

871 total citations · 1 hit paper
13 papers, 639 citations indexed

About

Bettina Hederer is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Biomedical Engineering. According to data from OpenAlex, Bettina Hederer has authored 13 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 1 paper in Biomedical Engineering. Recurrent topics in Bettina Hederer's work include Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (9 papers) and Respiratory and Cough-Related Research (6 papers). Bettina Hederer is often cited by papers focused on Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (9 papers) and Respiratory and Cough-Related Research (6 papers). Bettina Hederer collaborates with scholars based in Switzerland, Germany and United States. Bettina Hederer's co-authors include Kai Michael Beeh, Claus Vogelmeier, Klaus F. Rabe, Maureen Rutten‐van Mölken, Hendrik Schmidt, Leonardo M. Fabbri, Thomas Glaab, Thomas Meyer, Peter Brand and Michelle Clay and has published in prestigious journals such as New England Journal of Medicine, European Respiratory Journal and BMJ Open.

In The Last Decade

Bettina Hederer

13 papers receiving 604 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

2011 484 citations Claus Vogelmeier, Bettina Hederer et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bettina Hederer Switzerland	7	611	445	20	19	19	13	639
Lesley Towse United Kingdom	8	1.1k 1.8×	907 2.0×	36 1.8×	24 1.3×	22 1.2×	12	1.1k
Claes‐Göran Löfdahl Sweden	11	415 0.7×	338 0.8×	12 0.6×	16 0.8×	18 0.9×	13	477
M. Reza Maleki-Yazdi Canada	11	575 0.9×	464 1.0×	7 0.3×	25 1.3×	17 0.9×	21	610
Isabella Montagna Italy	5	966 1.6×	745 1.7×	41 2.0×	14 0.7×	16 0.8×	15	997
Catherine Francisco Italy	4	610 1.0×	482 1.1×	28 1.4×	7 0.4×	7 0.4×	6	628
Sabine Kattenbeck Germany	5	382 0.6×	270 0.6×	5 0.3×	26 1.4×	8 0.4×	10	406
Derek Skinner United Kingdom	10	269 0.4×	236 0.5×	13 0.7×	48 2.5×	19 1.0×	35	389
Pascale Nesme‐Meyer France	9	471 0.8×	286 0.6×	89 4.5×	15 0.8×	32 1.7×	11	505
Rebeca Baz Spain	5	316 0.5×	140 0.3×	15 0.8×	34 1.8×	28 1.5×	8	369
Hsin‐Kuo Ko Taiwan	12	205 0.3×	160 0.4×	18 0.9×	20 1.1×	28 1.5×	28	296

Countries citing papers authored by Bettina Hederer

Since Specialization

Citations

This map shows the geographic impact of Bettina Hederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Hederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Hederer more than expected).

Fields of papers citing papers by Bettina Hederer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Hederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Hederer. The network helps show where Bettina Hederer may publish in the future.

Co-authorship network of co-authors of Bettina Hederer

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Hederer. A scholar is included among the top collaborators of Bettina Hederer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Hederer. Bettina Hederer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Miravitlles, Marc, Gerard J. Criner, Marcus Mall, et al.. (2023). Potential systemic effects of acquired CFTR dysfunction in COPD. Respiratory Medicine. 221. 107499–107499. 6 indexed citations

2.

Vaidya, Soniya, et al.. (2021). Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers. Pulmonary Pharmacology & Therapeutics. 70. 102019–102019. 7 indexed citations

3.

Buhl, Roland, Weihua Cao, Christian Bartels, et al.. (2020). A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma. Pulmonary Pharmacology & Therapeutics. 62. 101919–101919. 11 indexed citations

4.

Buhl, Roland, Christian Bartels, Francesco Patalano, et al.. (2019). Mometasone furoate delivered via Breezhaler and Twisthaler in patients with asthma. PA4254–PA4254. 1 indexed citations

5.

Beeh, Kai Michael, Anne‐Marie Kirsten, Alexia Richard, et al.. (2018). Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study. International Journal of COPD. Volume 13. 3923–3936. 9 indexed citations

6.

Beasley, Richard, James F. Donohue, Rajendra H. Mehta, et al.. (2015). Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial. BMJ Open. 5(2). e006131–e006131. 22 indexed citations

7.

Beier, Jutta, et al.. (2014). Efficacy and safety of indacaterol acetate on ICS background therapy in asthma. European Respiratory Journal. 44(Suppl 58). P904–P904. 1 indexed citations

8.

Kanniess, Frank, et al.. (2014). Mometasone furoate delivered via the Breezhaler® and Twisthaler® devices in asthma. 44. 915. 4 indexed citations

9.

Beasley, Richard, Bob Lanier, István Várkonyi, et al.. (2012). Safety of once-daily QMF149 in patients with persistent asthma. 40. 2093. 2 indexed citations

10.

Beasley, Richard, et al.. (2012). Long-term efficacy of QMF149 in persistent asthma. 40. 1791. 1 indexed citations

11.

Vogelmeier, Claus, Bettina Hederer, Thomas Glaab, et al.. (2011). Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD. New England Journal of Medicine. 364(12). 1093–1103. 484 indexed citations breakdown →

12.

Brand, Peter, et al.. (2008). Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.. PubMed. 3(4). 763–70. 89 indexed citations

13.

Brand, Paul L.P., Bettina Hederer, Lesley Lowe, et al.. (2007). Flussabhängigkeit der Lungendeposition nach Inhalation von einem HFA-Dosieraerosol und dem Respimat® Soft Inhaler bei COPD Patienten. Pneumologie. 61(2). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact